New report explores open sale of low-THC cannabis products and regulatory responses in Europe
, section EMCDDA news
An increase in the open sale of cannabis products in Europe has raised questions around the possible legal and commercial status of these products. In a new report released today, Low-THC cannabis products in Europe, the EU drugs agency (EMCDDA) presents an initial overview of the current situation in this increasingly dynamic area. 21.12.2020
